Effects of combined levosimendan and vasopressin on pulmonary function in porcine septic shock

Inflammation

Volumn 35, Issue 3, 2012, Pages 871-880

  Ji, Muhuo ^a   Li, Renqi ^a   Li, Guo Min ^b   Fan, Yunxia ^b   Dong, Lin ^a   Yang, Jianjun ^a   Peng, Yong G ^c   Wu, Jing ^a  

^a NANJING UNIVERSITY   (China)

^b Jintan Hospital   (China)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Inflammatory responses; Oxygenation; Sepsis; Vasoactive agents

Indexed keywords

ARGIPRESSIN; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 10; INTERLEUKIN 6; LACTIC ACID; LEVOSIMENDAN; NITRATE; NITRITE; NORADRENALIN; TUMOR NECROSIS FACTOR ALPHA;

ACUTE LUNG INJURY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HISTOLOGY; LUNG ARTERY PRESSURE; LUNG FUNCTION; LUNG GAS EXCHANGE; LUNG HEMODYNAMICS; LUNG WET TO DRY WEIGHT RATIO; NONHUMAN; PERITONITIS; RESPIRATORY TRACT PARAMETERS; SCORING SYSTEM; SEPTIC SHOCK;

ANIMALS; ARGININE VASOPRESSIN; BLOOD PRESSURE; DRUG THERAPY, COMBINATION; FEMALE; HEMODYNAMICS; HMG-BOX DOMAINS; HYDRAZONES; INFLAMMATION; INTERLEUKIN-6; LACTIC ACID; LUNG; NITRATES; NITRITES; NOREPINEPHRINE; PERITONITIS; PULMONARY ARTERY; PULMONARY GAS EXCHANGE; PYRIDAZINES; RANDOM ALLOCATION; RESPIRATORY PHYSIOLOGICAL PHENOMENA; SHOCK, SEPTIC; SWINE;

SUS;

EID: 84863807856     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-011-9388-3     Document Type: Article

References (32)

1. Huebinger, R.M., R. Gomez, D. McGee, L.Y. Chang, J.E. Bender, T. O'Keeffe, A.M. Burris, S.M. Friese, G.F. Purdue, J.L. Hunt, B.D. Arnoldo, J.W. Horton, and R.C. Barber. 2010. Association of mitochondrial allele 4216C with increased risk for sepsis-related organ dysfunction and shock after burn injury. Shock 33(1): 19-23.
2. Tsushima, K., L.S. King, N.R. Aggarwal, A. De Gorordo, F.R. D'Alessio, and K. Kubo. 2009. Acute lung injury review. Internal Medicine 48(9): 621-630.
3. Patel, G.P., J.S. Grahe, M. Sperry, S. Singla, E. Elpern, O. Lateef, and R.A. Balk. 2010. Efficacy and safety of dopamine versus norepinephrine in the management of septic shock. Shock 33(4): 375-380.
4. Dellinger, R.P., M.M. Levy, J.M. Carlet, J. Bion, M.M. Parker, R. Jaeschke, K. Reinhart, D.C. Angus, C. Brun-Buisson, R. Beale, T. Calandra, J.F. Dhainaut, H. Gerlach, M. Harvey, J.J. Marini, J. Marshall, M.Ranieri, G. Ramsay, J. Sevransky, B.T. Thompson, S. Townsend, J.S. Vender, J.L. Zimmerman, and J.L. Vincent. 2008. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock. Intensive Care Medicine 4(1): 17-60.
5. Patel, B.M., D.R. Chittock, J.A. Russell, and K.R. Walley. 2002. Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology 96(3): 576-582. (Pubitemid 34193495)
6. Sun, Q.H., G. Dimopoulos, D.N. Nguyen, Z. Tu, N. Nagy, A.D. Hoang, P. Rogiers, D. De Backer, and J.L.Vincent. 2003. Low-dose vasopressin in the treatment of septic shock in sheep. American Journal of Respiratory and Critical Care Medicine 168(4): 481-486. (Pubitemid 37046879)
7. Landry, D.W., H.R. Levin, E.M. Gallant, R.C. Ashton Jr., S. Seo, D. D'Alessandro, M.C. Oz, and J.A. Oliver. 1997. Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 95(5): 1122-1125. (Pubitemid 27097820)
8. Boyd, J.H., C.L. Holmes, Y.J. Wang, H. Roberts, and K.R. Walley. 2008. Vasopressin decreases sepsis-induced pulmonary inflammation through the V2R. Resuscitation 79(2): 325-331.
9. Westphal, M., S. Rehberg, M.O. Maybauer, D.M. Maybauer, P. Enkhbaatar, B.B. Westphal-Varghese, F.C. Schmalstieg, N. Morita,R.A. Cox, L.D. Traber, H. Hawkins, E. Whorton, and D.L. Traber. 2011. Cardiopulmonary effects of low-dose arginine vasopressin in ovine acute lung injury. Critical Care Medicine 39(2): 357-363.
10. + channel in rat arterial myocytes. European Journal of Pharmacology 333(2-3): 249-259.
11. Morelli, A., J.L. Teboul, S.M. Maggiore, A. Vieillard-Baron, M. Rocco, G. Conti, A. De Gaetano, U. Picchini, A. Orecchioni, I. Carbone, L. Tritapepe, P. Pietropaoli, and M. Westphal. 2006. Effects of levosimendan on right ventricular afterload in patients with acute respiratory distress syndrome: a pilot study. Critical Care Medicine 34(9): 2287-2293. (Pubitemid 44260011)
12. Scheiermann, P., D. Ahluwalia, S. Hoegl, A. Dolfen, M. Revermann, B. Zwissler, H. Muhl, K.A. Boost, and C. Hofstetter. 2009. Effects of intravenous and inhaled levosimendan in severe rodent sepsis. Intensive Care Medicine 35(8): 1412-1419.
13. Parissis, J.T., S. Adamopoulos, C. Antoniades, G. Kostakis, A. Rigas, S. Kyrzopoulos, E. Iliodromitis, and D. Kremastinos. 2004. Effects of levosimendan on circulating pro-inflammatory cytokines and soluble apoptosis mediators in patients with decompensated advanced heart failure. The American Journal of Cardiology 93(10): 1309-1312. (Pubitemid 38595693)
14. Rehberg, S., C. Ertmer, J.L. Vincent, H.U. Spiegel, G. Köhler, M. Erren, M. Lange, A. Morelli, J. Seisel, F. Su, H. Van Aken, D.L. Traber, and M. Westphal. 2010. Effects of combined arginine vasopressin and levosimendan on organ function in ovine septic shock. Critical Care Medicine 38(10): 2016-2023.
15. Gloor, B., T.A. Blinman, D.A. Rigberg, K.E. Todd, J.S. Lane, O.J. Hines, and H.A. Reber. 2000. Kupffer cell blockade reduces hepatic and systemic cytokine levels and lung injury in hemorrhagic pancreatitis in rats. Pancreas 21(4): 414-420.
16. Leone, M., and W.A. Boyle. 2006. Decreased vasopressin responsiveness in vasodilatory septic shock-like condition. Critical Care Medicine 34(4): 1126-1130.
17. Asfar, P., M. Pierrot, N. Veal, F. Moal, F. Oberti, V. Croquet, O.Douay, Y. Gallois, J.L. Saumet, P. Alquier, and P. Calès. 2003. Low-dose terlipressin improves systemic and splanchnic hemodynamics in fluid-challenged endotoxic rats. Critical Care Medicine 31(1): 215-220. (Pubitemid 36151174)
18. García-Septien, J., J.A. Lorente, M.A. Delgado, M. de Paula, N. Nin, A. Moscoso, A. Sánchez-Ferrer, F. Perez-Vizcaino, and A. Esteban. 2010. Levosimendan increases portal blood flow and attenuates intestinal intramucosal acidosis in experimental septic shock. Shock 34(3): 275-280.
19. Lee, R.P., D. Wang, S.J. Kao, and H.I. Chen. 2001. The lung is the major site that produces nitric oxide to induce acute pulmonary oedema in endotoxin shock. Clinical and Experimental Pharmacology and Physiology 28(4): 315-320. (Pubitemid 32250720)
20. Chen, L.W., B. Hwang, W.J. Chang, J.S. Wang, J.S. Chen, and C.M. Hsu. 2004. Inducible nitric oxide synthase inhibitor reverses exacerbating effects of hypertonic saline on lung injury in burn. Shock 22(5): 472-477. (Pubitemid 39472573)
21. Sareila, O., R. Korhonen, H. Auvinen, M. Hämäläinen, H. Kankaanranta, E. Nissinen, and E. Moilanen. 2008. Effects of levo-and dextrosimendan on NF-kappa B-mediated transcription, iNOS expression and NO production in response to inflammatory stimuli. British Journal of Pharmacology 155(6): 884-895.
22. Umino, T., E. Kusano, S.Muto, T. Akimoto, S. Yanagiba, S. Ono, M. Amemiya, Y. Ando, S. Homma, U. Ikeda, K. Shimada, and Y. Asano. 1999.AVP inhibits LPS- and -IL-1β stimulated NO and cGMP via V1 receptor in cultured rat mesangial cells. American Journal of Physiology 276(3 Pt 2): F433-F441. (Pubitemid 29157536)
23. Ware, L.B., T. Koyama, D.D. Billheimer, W. Wu, G.R. Bernard, B. T. Thompson, R.G. Brower, T.J. Standiford, T.R. Martin, and M.A. Matthay. 2010. Prognostic and pathogenetic value of combining clinical and biochemical indices in patients with acute lung injury. Chest 137(2): 288-296.
24. Casey, L.C., R.A. Balk, and R.C. Bone. 1993. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Annals of Internal Medicine 119(8): 771-778. (Pubitemid 24012641)
25. Echtenacher, B., D.N. Mannel, and L. Hultner. 1996. Critical protective role of mast cells in a model of acute septic peritonitis. Nature 38(6577): 75-77. (Pubitemid 26130005)
26. Wang, H., H. Yang, and K.J. Tracey. 2004. Extracellular role of HMGB1 in inflammation and sepsis. Journal of Internal Medicine 255(3): 320-331. (Pubitemid 38324549)
27. Wang, H., H. Liao, M. Ochani, M. Justiniani, X. Lin, L. Yang, Y. Al-Abed, H. Wang, C. Metz, E.J. Miller, K.J. Tracey, and L. Ulloa. 2004. Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Natural Medicine 10(11): 1216-1221. (Pubitemid 39540438)
28. Wolfson, R.K., E.T. Chiang, and J.G. Garcia. 2011. HMGB1 induces human lung endothelial cell cytoskeletal rearrangement and barrier disruption. Microvascular Research 81(2): 189-197.
29. Perl, M., C.S. Chung, U. Perl, J. Lomas-Neira, M. de Paepe, W.G. Cioffi, and A. Ayala. 2007. Fas-induced pulmonary apoptosis and inflammation during indirect acute lung injury. American Journal of Respiratory and Critical Care Medicine 176(6): 591-601. (Pubitemid 47403277)
30. Oberbeck, R., D. Schmitz, K. Wilsenack, M. Schüler, B. Pehle, M. Schedlowski, and M.S. Exton. 2002. Adrenergic modulation of survival and cellular immune functions during polymicrobial sepsis. Neuroimmunomodulation 11(4): 214-223. (Pubitemid 38916093)
31. Filierl, M.A., D. Rittirsch, B.A. Nadeau, A.J. Chen, J.V. Sarma, F.S. Zetoune, S.R. McGuire, R.P. List, D.E. Day, L.M. Hoesel, H. Gao, N. Van Rooijen, M.S. Huber-Lang, R.R. Neubig, and P.A. Ward. 2007. Phagocyte-derived catecholamines enhance acute inflammatory injury. Nature 449(7163): 721-725. (Pubitemid 47552095)
32. Levy, B., C. Vallee, F. Lauzier, G.E. Plante, A. Mansart, J.P. Mallie, and O. Lesur. 2004. Comparative effects of vasopressin, norepinephrine, and L-canavanine, a selective inhibitor of inducible nitric oxide synthase, in endotoxic shock. American Journal of Physiology. Heart and Circulatory Physiology 287(1): H209-H215. (Pubitemid 38802355)